trial

Compassion Focused Therapy for Distressing Experiences

NCTId NCT02733575
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 9 (actual)
Sponsored by King's College London
Primary completion 2019-01-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
9 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2015-09
Primary completion
2019-01-08
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Compassion Focused Therapy

Sponsors

King's College LondonLead Sponsor

Investigators

1
Charlie Heriot-Maitland, DClinPsychPrincipal Investigator

Sites

1 total
London, United Kingdom

Facts & assertions

4 sourced
Enrollment
9
Phase
NA
Primary Completion Date
2019-01-08
Status
COMPLETED
relationships
The graph out of here
drug
Compassion Focused Therapy
drug
lead_sponsor
King's College London
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Charlie Heriot-Maitland, DClinPsych
person